Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.
economic
hepatitis C virus
pregnancy
testing
treatment
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
02 11 2021
02 11 2021
Historique:
received:
20
12
2019
pubmed:
14
4
2020
medline:
11
11
2021
entrez:
14
4
2020
Statut:
ppublish
Résumé
To inform proposed changes in hepatitis C virus (HCV) screening guidelines in the United States, we assessed the cost-effectiveness of HCV antenatal rescreening for women without evidence of HCV during a prior pregnancy, using a previously published model. Universal HCV rescreening among pregnant women was cost-effective (incremental cost-effectiveness ratio, $6000 per quality-adjusted life-year) and should be recommended nationally.
Identifiants
pubmed: 32282879
pii: 5819607
doi: 10.1093/cid/ciaa362
pmc: PMC8563211
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e3355-e3357Subventions
Organisme : Gilead Sciences
Organisme : NIAID NIH HHS
ID : R01 AI147490
Pays : United States
Organisme : NIAAA NIH HHS
ID : K01 AA027733
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA023356
Pays : United States
Organisme : University of San Diego Center for AIDS Research
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Clin Infect Dis. 2019 Nov 13;69(11):1888-1895
pubmed: 30689769
MMWR Morb Mortal Wkly Rep. 2017 May 12;66(18):470-473
pubmed: 28493860
JAMA. 2020 Mar 10;323(10):970-975
pubmed: 32119076
J Hepatol. 2016 Jul;65(1):17-25
pubmed: 26867489
Natl Vital Stat Rep. 2019 Nov;68(13):1-47
pubmed: 32501202
Open Forum Infect Dis. 2018 Feb 17;5(3):ofy043
pubmed: 29564364
Can J Gastroenterol Hepatol. 2019 Jun 2;2019:8654741
pubmed: 31275902
Am J Med. 2018 Jan;131(1):64-71.e1
pubmed: 28807713
Obstet Gynecol. 2019 Feb;133(2):289-300
pubmed: 30633134
Ann Intern Med. 2017 Jun 6;166(11):775-782
pubmed: 28492929
Paediatr Perinat Epidemiol. 2019 Jan;33(1):O1-O4
pubmed: 30346060
Subst Abus. 2016;37(1):88-95
pubmed: 26569631